Viewing Study NCT05577000


Ignite Creation Date: 2025-12-26 @ 12:19 PM
Ignite Modification Date: 2025-12-26 @ 12:19 PM
Study NCT ID: NCT05577000
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-13
First Post: 2022-10-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
Sponsor: Thomas Martin, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module